Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells

[1]  N. Sidell,et al.  Effects of interferon‐gamma and its interaction with retinoic acid on human neuroblastoma differentiation , 2007, International journal of cancer.

[2]  Randal K. Wada,et al.  Differentiating Effects of 1,25‐Dihydroxycholecalciferol (D3) on LA‐N‐5 Human Neuroblastoma Cells and Its Synergy with Retinoic Acid , 1995, Journal of pediatric hematology/oncology.

[3]  S. Shack,et al.  Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells , 1995, International journal of cancer.

[4]  M. Deppe,et al.  Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone. , 1993, Anti-cancer drugs.

[5]  R. Coombes,et al.  EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. , 1992, Biochemical pharmacology.

[6]  J. Rhim,et al.  Relative resistance to 1,25-dihydroxyvitamin D3 in a keratinocyte model of tumor progression. , 1992, The Journal of biological chemistry.

[7]  L. Binderup,et al.  20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. , 1991, Biochemical pharmacology.

[8]  Clifford J. Tabin,et al.  Retinoids, homeoboxes, and growth factors: Toward molecular models for limb development , 1991, Cell.

[9]  H. Koeffler,et al.  1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Lando,et al.  Modulation of intracellular cyclic adenosine monophosphate levels and the differentiation response of human neuroblastoma cells. , 1990, Cancer research.

[11]  E. Abemayor,et al.  Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. , 1989, Environmental health perspectives.

[12]  R. Weinberg,et al.  N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma , 1986, Cell.

[13]  R. Kennett,et al.  Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Young,et al.  Cancer incidence, survival, and mortality for children younger than age 15 years , 1986, Cancer.

[15]  H. Koeffler,et al.  1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. , 1985, Cancer treatment reports.

[16]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[17]  H. DeLuca,et al.  Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. , 1984, Cancer research.

[18]  G. Kreutzberg,et al.  Regulation of acetylcholinesterase activity by retinoic acid in a human neuroblastoma cell line. , 1984, Experimental cell research.

[19]  M. Haussler,et al.  1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells , 1984, The Journal of cell biology.

[20]  A. Evans,et al.  A review of 17 IV‐S neuroblastoma patients at the children's hospital of Philadelphia , 1980, Cancer.

[21]  D. Peehl,et al.  Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. , 1995, Endocrinology.

[22]  S. de Vos,et al.  Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels. , 1995, Leukemia research.

[23]  W. Yu,et al.  1,25-Dihydroxyvitamin D3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line. , 1995, Cancer investigation.

[24]  M. Israel,et al.  Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate. , 1988, Experimental cell biology.

[25]  M. Israel,et al.  Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma , 1985, Nature.